Inventor
MAINOLFI NELLO
US43 patents
⚠️ This page may combine multiple inventors who share the name “MAINOLFI NELLO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KYMERA THERAPEUTICS INC
22 patentsUS10874743B2Dec 29, 2020
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC38 citations98
US11352350B2Jun 7, 2022
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC20 citations94
US11117889B1Sep 14, 2021
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC28 citations94
US12258341B2Mar 25, 2025
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC5 citations86
US12168057B2Dec 17, 2024
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC5 citations86
US11807636B2Nov 7, 2023
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC6 citations86
US11746120B2Sep 5, 2023
Stat degraders and uses thereof
KYMERA THERAPEUTICS INC12 citations86
US11723980B2Aug 15, 2023
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC9 citations86
US11512080B2Nov 29, 2022
CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC15 citations86
US11485743B2Nov 1, 2022
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC6 citations86
US11485750B1Nov 1, 2022
STAT degraders and uses thereof
KYMERA THERAPEUTICS INC7 citations86
US11358948B2Jun 14, 2022
CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC16 citations86
US11318205B1May 3, 2022
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC10 citations83
US12077555B2Sep 3, 2024
STAT degraders and uses thereof
KYMERA THERAPEUTICS INC3 citations75
US12006329B2Jun 11, 2024
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC4 citations75
US12150995B2Nov 26, 2024
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC4 citations74
US11623932B2Apr 11, 2023
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC3 citations73
US12091411B2Sep 17, 2024
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC5 citations71
US12516068B2Jan 6, 2026
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC1 citations64
US12540127B2Feb 3, 2026
CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC0 citations62
US11932635B2Mar 19, 2024
CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC1 citations62
US12545659B2Feb 10, 2026
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations51
RAZE THERAPEUTICS INC
8 patentsUS11014882B2May 25, 2021
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
RAZE THERAPEUTICS INC3 citations72
US10954220B2Mar 23, 2021
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
RAZE THERAPEUTICS INC3 citations72
US11370792B2Jun 28, 2022
Caffeine inhibitors of MTHFD2 and uses thereof
RAZE THERAPEUTICS INC2 citations69
US12264132B2Apr 1, 2025
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
RAZE THERAPEUTICS INC0 citations62
US11634412B2Apr 25, 2023
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
RAZE THERAPEUTICS INC0 citations62
US11535593B2Dec 27, 2022
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
RAZE THERAPEUTICS INC1 citations62
US12187728B2Jan 7, 2025
Caffeine inhibitors of MTHFD2 and uses thereof
RAZE THERAPEUTICS INC0 citations59
US11091451B2Aug 17, 2021
SHMT inhibitors and uses thereof
RAZE THERAPEUTICS INC0 citations51
ARTMAN III GERALD DAVID
6 patentsUS8501756B2Aug 6, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID65 citations96
US8242125B2Aug 14, 2012
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID3 citations61
US8541432B2Sep 24, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID0 citations50
US8492393B2Jul 23, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID0 citations50
US8486954B2Jul 16, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID0 citations50
US8431584B2Apr 30, 2013
Heterobicyclic carboxamides as inhibitors for kinases
ARTMAN III GERALD DAVID0 citations50
ADAMS CHRISTOPHER MICHAEL
3 patentsUS9056874B2Jun 16, 2015
Complement pathway modulators and uses thereof
ADAMS CHRISTOPHER MICHAEL95 citations96
US9682968B2Jun 20, 2017
Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof
ADAMS CHRISTOPHER MICHAEL15 citations83
US9475806B2Oct 25, 2016
Complement factor B inhibitors and uses there of
ADAMS CHRISTOPHER MICHAEL6 citations71